Stifel Maintains Structure Therapeutics(GPCR.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsJan 8 07:34 ET · Ratings

Stifel Initiates Structure Therapeutics(GPCR.US) With Buy Rating, Announces Target Price $50

Moomoo NewsJan 7 18:31 ET · Ratings

FDA Issues Draft Guidance on Developing Weight Loss Drugs

Seeking AlphaJan 7 11:53 ET

Viking Therapeutics, Structure Therapeutics Positioned As Key Pharma Partners For Weight Loss Products: Analyst

BenzingaJan 6 14:53 ET

SA Asks: Which Biotechs Are Most Likely to Be Acquired Near-term?

Seeking AlphaJan 5 17:32 ET

Weight-loss Drugs in 2025, Auto Industry Outlook: Market Domination

Yahoo FinanceDec 24, 2024 14:40 ET